Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2

Overview of attention for article published in Frontiers in Pharmacology, January 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 20,307 followers.

@devaraj227 @ydeigin @alexandrosM you can check for example here: https://t.co/ZtuH3CPZPM for more compound-based screening plattforms maybe here: https://t.co/6uOeJqB60a and also here: https://t.co/vQoKOGsjNQ 2/

RT @cispt2: Here's a new @ncats_nih_gov paper we have out, wrapping up our drug repurposing screening on CoV-2 using CPE assays. All data a…

RT @cispt2: Here's a new @ncats_nih_gov paper we have out, wrapping up our drug repurposing screening on CoV-2 using CPE assays. All data a…

RT @cispt2: Here's a new @ncats_nih_gov paper we have out, wrapping up our drug repurposing screening on CoV-2 using CPE assays. All data a…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.